ArticleMolecular and clinical oncology2021

Analysis of efficacy, safety and prognostic factors of DAC-HAA treatment in Chinese pediatric patients with refractory or relapsed acute myeloid leukemia.

Liang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.